Status | Study |
Active, not recruiting |
Study Name: Male Breast Cancer: Understanding the Biology for Improved Patient Care Condition: Breast Cancer Date: 2010-04-09 |
Active, not recruiting |
Study Name: Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2010-03-08 Interventions: Drug: vorinostat Given orally |
Completed |
Study Name: Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007 Condition: Breast Cancer Date: 2008-10-15 |
Active, not recruiting |
Study Name: Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2008-06-17 Interventions: Biological: cixutumumab Given |
Completed |
Study Name: A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2005-10-25 Interventions: Drug: cediranib maleate Given |
Terminated |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2005-08-16 Interventions: Drug: vorinostat Given PO |
Completed |
Study Name: Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer Condition: Breast Cancer Breast Neoplasms, Male Date: 2005-03-18 Interventions: Drug: pemetrexed 600 mg/m2, intravenous (IV), every 14 days until complete response or disease progressi |
Completed |
Study Name: FR901228 in Treating Patients With Metastatic Breast Cancer Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2004-12-07 Interventions: Drug: romidepsin Given IV |
Completed |
Study Name: Sorafenib in Treating Patients With Metastatic Breast Cancer Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2004-11-09 Interventions: Drug: sorafenib tosylate Given |
Terminated |
Study Name: 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer Condition: Male Breast Cancer Recurrent Breast Cancer Date: 2004-11-09 Interventions: Drug: triapine Given IV |